|
|||||
|
|
A tumor-targeting nanomedicine carrying the p53 gene crosses the blood–brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma |
|
| Authors: | Sang-Soo Kim Joe B Harford Manish Moghe Tiffani Slaughter Caroline Doherty Esther H Chang |
| Institution: | 1. Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC
SynerGene Therapeutics, Inc., Potomac, MD;2. SynerGene Therapeutics, Inc., Potomac, MD;3. Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC |
| Abstract: | |
| Keywords: | anti-PD-1 glioblastoma nanomedicine p53 tumor-targeted delivery |